Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

Published Date: 17 Jun 2024

News, features, and commentary about cancer-related issues

Read Full News

Latest News

US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry

The U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less...

Low Income, Education Tied to Depression in Older Adults

Older adults with chronic disease who have less education, lower income, and no active jobs tend to experience symptoms of depression.

Why Encouragement May Not Improve Motivation in Depression

A meta-analysis identifies impaired effort-based decision making across psychiatric disorders, pointing to actionable targets for improving motivation and functional outcomes.

Brexpiprazole Safe, Effective in Early-Episode Schizophrenia

Brexpiprazole is linked to reduced symptoms, improved functioning, and greater response compared with placebo in patients with early-episode schizophrenia, new research shows.

Do Anatomy Atlases Reflect Social Inequalities?

Historical anatomical illustrations reflect social inequality and may require an ethical context to guide their continued use in clinical education and surgical reference.

Novel Psychedelic Promising on Resistant Depression

An investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression symptoms compared to placebo, a phase 2b trial shows.

Todays Updates

Which Risk Model Better Identifies High-Risk Smoldering MM?

A cohort study compares the distribution and progression risk among individuals classified as having high-risk smoldering multiple myeloma by the AQUILA trial inclusion criteria vs 2/20/20 risk model.

Todays Updates

Which Risk Model Better Identifies High-Risk Smoldering MM?

A cohort study compares the distribution and progression risk among individuals classified as having high-risk smoldering multiple myeloma by the AQUILA trial inclusion criteria vs 2/20/20 risk model.

Latest News

The U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less...

Older adults with chronic disease who have less education, lower income, and no active jobs tend to experience symptoms of depression.

A meta-analysis identifies impaired effort-based decision making across psychiatric disorders, pointing to actionable targets for improving motivation and functional outcomes.

Brexpiprazole is linked to reduced symptoms, improved functioning, and greater response compared with placebo in patients with early-episode schizophrenia, new research shows.

Historical anatomical illustrations reflect social inequality and may require an ethical context to guide their continued use in clinical education and surgical reference.

An investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression symptoms compared to placebo, a phase 2b trial shows.

News All Time

Making informed decisions and managing regret after prostate cancer treatment

A prostate cancer diagnosis and life during and after treatments can feel overwhelming. Alongside the shock of a diagnosis, you may be faced with multiple treatment options and asked to make a choice—surgery, radiation ...

Nasal therapeutic HPV vaccine could prevent cervical cancer

Cervical cancer, which affects the reproductive tract, is one of the most common cancers in women worldwide. It is primarily caused by human papillomavirus (HPV), a viral infection that spreads through sexual contact.

Newly identified T-cell subtype may explain treatment-resistant childhood leukemia

A new type of cancer cell that "warrants urgent investigation" has been discovered in childhood leukemia and could impact clinical care. Research into new or repurposed treatments that target this new cell type could give ...

Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities

For more than a year, Diane Hunter, now 72, had been experiencing vague symptoms—pain in her spine and hips, nausea, exhaustion, thirst, and frequent urination. Her primary care physician had ruled out diabetes before finally ...

Doctors say lung cancer is still the deadliest cancer, but hope is growing

Lung cancer remains the leading cause of cancer death in the U.S., responsible for about 1 in 4, but major advances in screening, surgery and personalized treatment are helping more patients live longer.

GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor agonists—the class of drugs behind Ozempic, Wegovy and Mounjaro, for example—may do more than regulate ...

Best foot forward—chemo care should include podiatry, say researchers

Irreversible nerve damage to the lower limbs is a common side effect of chemotherapy, yet up to 50% of patients are missing out on vital foot care that could significantly ease their symptoms, according to new research from ...

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a chemical imaging probe that resists the breakdown of certain compounds in the body, giving doctors a more dependable way ...

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

Long-term breast cancer survivors have a higher risk for developing depression, particularly if they have insomnia, according to a study published online Oct. 10 in SLEEPJ.

New study elucidates obesity's role in fueling breast cancer progression

Obesity and cancer are two major health challenges of our time, yet the link between them remains only partially understood. New research now highlights a molecular chain of events in estrogen receptor-positive breast cancer, ...

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

Bacteria are rapidly emerging as a new class of "living medicines" used to kill cancer cells.

Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer

Aerobic and resistance exercise can significantly improve physical performance in patients living with metastatic breast cancer, according to new results presented at the Advanced Breast Cancer Eighth International Consensus ...

Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western Hemisphere, affecting approximately 200,000 people in the United States.

Advanced breast cancer patients living longer thanks to improvements in treatment and care

People diagnosed with advanced breast cancer in 2025 can expect to live for an extra six or seven months, compared to the average survival time for patients diagnosed in 2011, according to a major study of patient data in ...

Data-driven risk stratification guides childhood brain tumor treatment, reducing side effects

By analyzing data from three clinical trials treating children with the brain tumor medulloblastoma, scientists at St. Jude Children's Research Hospital have designed an approach to safely reduce therapy, thereby lowering ...

Radiotherapy after mastectomy can be avoided, study finds

Radiotherapy can be safely omitted as a treatment for many breast cancer patients who have had a mastectomy and are taking anti-cancer drugs, a study shows.

Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia

EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.

Participate and win cash vouchers

Get updates on the latest events happening around the world

2.

Insurance Claim Denials for Preventive Care More Common in At-Risk Patients

3.

ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing?

4.

Immunotherapy after surgery is good for patients with advanced cancer

5.

Alecensa (alectinib) Offers Hope for Certain Patients With ALK Positive NSCLC

1.

Cerebrospinal Fluid Metabolite Biomarkers in Central Nervous System Tumor Monitoring: A New Frontier

2.

Introduction To Immune Thrombocytopenic Purpura

3.

Demystifying the Mentzer Index: Understanding Its Importance in Inventory Management

4.

The Ins and Outs of Glossectomy: What You Need to Know

5.

What is Hemorrhagic Cystitis and How to Manage its Symptoms

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

2.

Efficient Management of First line ALK-rearranged NSCLC - Part V

3.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

4.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

Latest News

US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry

Low Income, Education Tied to Depression in Older Adults

Why Encouragement May Not Improve Motivation in Depression

Brexpiprazole Safe, Effective in Early-Episode Schizophrenia

Do Anatomy Atlases Reflect Social Inequalities?

Novel Psychedelic Promising on Resistant Depression

Todays Updates

Which Risk Model Better Identifies High-Risk Smoldering MM?

Todays Updates

Which Risk Model Better Identifies High-Risk Smoldering MM?

Latest News

News All Time

Making informed decisions and managing regret after prostate cancer treatment

Nasal therapeutic HPV vaccine could prevent cervical cancer

Newly identified T-cell subtype may explain treatment-resistant childhood leukemia

Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities

Doctors say lung cancer is still the deadliest cancer, but hope is growing

GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

Best foot forward—chemo care should include podiatry, say researchers

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

New study elucidates obesity's role in fueling breast cancer progression

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer

Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

Advanced breast cancer patients living longer thanks to improvements in treatment and care

Data-driven risk stratification guides childhood brain tumor treatment, reducing side effects

Radiotherapy after mastectomy can be avoided, study finds

Recommended News For You

First-Line HCC Trial's Lenvatinib-Pembrolizumab Combo Misses Target.